Search Results 201-210 of 17409 for Mmol

1. A Study to Compare Cabozantinib versus Sunitinib to Treat Metastatic Variant Histology Renal Cell Carcinoma Patients - Mayo Clinic

   Urine protein/creatinine ratio (UPCR) ≤ 1 mg/mg (≤ 113.2 mg/mmol). The subject is capable of understanding and complying with the protocol requirements ...

2. Losartan for Outpatients on COVID-19 - Clinical Trials

   Potassium > 5.0 mmol/L (must have been measured within 1 month) of enrollment. Concurrent treatment with aliskiren. Inability to obtain informed consent ...

3. Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma - Mayo Clinic

   Hemoglobin ≥ 7.5 g/dL (4.7 mmol/L);; Serum aspartate transaminase (AST/SGOT) and alanine transaminase (ALT/SGPT) ≤ 3.0 x upper limit of normal (ULN). In ...

4. A Prospective Study to Establish a New Onset Hyperglycemia and Diabetes (NOD) Cohort - Mayo Clinic

   2h Post Glucose (PG) ≥ 200mg (11.1 mmol/L) during OGTT (oral glucose tolerance test); or. Any (1) PDM present followed by an anti-diabetes medication ...

5. Testing the Addition of an Anti-cancer Drug, ASTX727, to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer - Mayo Clinic

   ... mmol/L(within 14 days of registration) - Criteria must be met without packed red blood cell (pRBC) transfusion within the prior 2 weeks. Participants can be ...

6. A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD) - Mayo Clinic

   Serum sodium levels < 130 mmol/L. Cannot be taking any other experimental medications. Require ventilator support. Taking medications known to induce CYP3A4 ...

7. A Study of Mogamulizumab Combined with Nivolumab in Patients who have Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

   Hemoglobin ≥ 10.0 g/dL (6.2 mmol/L);; Serum total bilirubin ≤ 1.5 × ULN (except subjects with Gilbert syndrome, who can have total bilirubin < 3.0 mg/dL); ...

8. Study to Assess Safety and Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid - Mayo Clinic

   A history of bone marrow disorder including aplastic anemia, or marked anemia defined as hemoglobin < 10.0 g/dL (or 6.2 mmol/L). Any condition which, in the ...

9. A Study to Evaluate a Single Dose of DCR-PHXC in Patients with Primary Hyperoxaluria Type 3 - Mayo Clinic

   24-hour Uox excretion ≥ 0.7 mmol (adjusted per 1.73 m^2 BSA in participants < 18 years of age) in both collections performed in the screening period. Less ...

10. A Study of the Effect of Dalcetrapib on Cardiovascular Risk for a Genetically Defined Population who have had a Recent Acute Coronary Syndrome Event - Mayo Clinic

    ... mmol/L). Exclusion Criteria: Females who are pregnant or breast-feeding. A negative pregnancy test required for all women of child-bearing potential at visit ...